Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1285953 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL2701578 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL30168486 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL14718529 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8389087 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL11221318 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL6565430 | 0.99 | PRKCA (0.59) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL14957317 | 0.93 | PRKCA (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL6324925 | 0.93 | PRKCA (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL31326010 | 0.92 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118922179-A | Super-activated lipid nanoparticles | 科纳治疗公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118843455-A | Immunogenic mRNA delivery vehicles | 科纳治疗公司 | 2024-10-25 | — | — | CN | claimed |
| CN-117051019-A | Novel coronavirus vaccine, preparation method and application thereof | 江苏瑞科生物技术股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | claimed |
| CN-118922179-A | Super-activated lipid nanoparticles | 科纳治疗公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118843455-A | Immunogenic mRNA delivery vehicles | 科纳治疗公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-114302741-A | Compositions and methods for treating autoimmune disorders | 密执安大学评议会 | 2022-04-08 | — | — | CN | disclosed |